Interferon Alfa-n3 (Alferon N)

Alferon N (interferon alfa‑n3) is covered only for the FDA‑approved indication of refractory or recurring external genital warts (condyloma acuminatum); off‑label uses are not supported. Coverage requires no anaphylactic sensitivity to egg protein, neomycin, or mouse IgG and is authorized for up to 16 weeks.

"Condyloma acuminatum, refractory or recurring external genital warts"

Sign up to see full coverage criteria, indications, and limitations.